期刊文献+

磷脂酰肌醇蛋白聚糖-3的表达在肝细胞癌诊断中的意义 被引量:8

Significance of glypican-3 immunohistochemistry in diagnosis of hepatocellular carcinoma
原文传递
导出
摘要 目的 探讨磷脂酰肌醇蛋白聚糖-3( GPC3)免疫组织化学染色在肝细胞癌病理诊断的应用价值。方法 制作14个含731例肝肿瘤和肿瘤旁肝组织芯片,其中肝细胞癌357例、胆管癌26例、肝细胞癌癌旁肝组织包括肝硬化171例、血管瘤旁肝组织93例、肝转移癌84例。全部病例采用免疫组织化学检测GPC3(1G12克隆)蛋白表达,实验设阳性对照。结果 72.0%的肝细胞癌(257/357)GPC3呈阳性反应,其余374例非肝细胞癌病例均为阴性,包括胆管癌、肝转移癌、肝细胞癌癌旁肝组织(包括肝硬化和血管瘤旁肝组织)。GPC3阳性率在不同的肝细胞癌组织学分级的差异有统计学意义(P<0.01),阳性率高低排列为Ⅲ级(77.1%,64/83)、Ⅱ级(73.3%,187/255)、Ⅰ级6/12和Ⅳ级(0)为阴性。结论 GPC3免疫组织化学检测是肝细胞癌诊断的良好指标,敏感性达72.0%;也是区别瘤旁肝组织和肝转移癌的鉴别诊断指标,其特异性达100%。 ObjectiveTo explore the diagnostic significance of glypican-3 (GPC3)immunohistochemistry in hepatocellular carcinoma (HCC). Methods Fourteen tissue microarray paraffin blocks were constructed, which comprised 731 samples from hepatic tumors and paratumor tissues, including 357 cases of HCC, 26 cholangiocarcinoma, 171 HCC adjacent hepatic tissue including cirrhosis,93 hemangioma adjacent hepatic tissues, and 84 carcinomas metastatic to liver. GPC3 (Clone 1G12) protein was detected immunohistochemically in all of cases with positive controls. Results GPC3 protein was positive in 72. 0% HCC (257/357), but negative in the rest 374 of non-HCC cases, including cholangiocarcinoma, HCC adjacent hepatic tissue including cirrhosis, hemangioma adjacent hepatic tissues and metastatic carcinomas. GPC3 positive percentage was significantly correlated with histological grading of HCC (P 〈0. 01 ), highest in grade 3 (77. 1% ,64/83 ) followed by grade 2 ( 73. 3%, 187/255 ), grade 1(6/12) and grade4 (0). Conclusions GPC3 is a valuable diagnostic marker for hepatocellular carcinoma with sensitivity of 72. 0%, and a differential diagnostic marker from tumor adjacent hepatic tissue and carcinomas metastatic to liver with specificity of 100%.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2011年第9期626-629,共4页 Chinese Journal of Pathology
基金 澳门科学技术发展基金(068/2009/A)
关键词 肝肿瘤 肝细胞 磷脂酰肌醇蛋白聚糖类 Liver neoplasms Carcinoma, hepatocellular Glypican
  • 相关文献

参考文献1

共引文献43

同被引文献45

  • 1Research Center of Clinical Medicine,Affiliated Hospital of Nantong University,Nantong 226001,China (Yao M,Yao DF,Qiu LW,Wu W,Sai WL,Yang JL and Zhang HJ),Department of Oncology,Yancheng First People’s Hospital,Yancheng 224001,China (Bian YZ),Department of Oncology,Second Affiliated Hospital,Nanjing Medical University,Nanjing 210011,China (Zhang CG).Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2011,10(3):289-294. 被引量:52
  • 2Jiang Long,Zhen-Wei Lang,Hua-Guang Wang,Tai-Ling Wang,Bao-En Wang and Si-Qi Liu Liver Research Center,Beijing Friendship Hospital, Capital Medical University,Beijing 100050,China,Department of Hepatology,Department of Pathology, Beijing Youan Hospital,Capital Medical University,Beijing 100069,China,Department of Pharmaceutical Affairs,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,China,Department of Pathology,China-Japan Friendship Hospital,Beijing 100029,China,Beijing Genomics Institute,Chinese Academy of Science,Beijing Airport Industrial Zone B-6,Shunyi,Beijing 101300,China.Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected smal hepatocel ular carcinomas[J].Hepatobiliary & Pancreatic Diseases International,2010,9(3):296-305. 被引量:21
  • 3Louis L,Tamara S,David C,潘敏鸿(摘译),饶秋(摘译),周晓军(审校).GPC3在鉴别小肝癌与肝硬化、异型增生结节和局灶性结节性增生中的作用[J].临床与实验病理学杂志,2006,22(6):653-653. 被引量:44
  • 4周新木,徐少杰,朱忆凌.CDx2和Hep在胃癌组织中的表达及临床意义[J].中国基层医药,2006,13(12):1947-1948. 被引量:2
  • 5王莉,惠宁,满晓波,唐亮.GPC3在卵巢癌中的表达及其临床意义[J].解放军医学杂志,2007,32(10):1017-1019. 被引量:3
  • 6Tiao GM,Bobey N,AHen S. The current management of hepatohlastoma:A combination of chemotherapy,conventional resection and liver transplantation[J].{H}Journal of Pediatrics,2005,(02):204-211.
  • 7Wang FH,Yip YC,Zhang M. Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy[J].{H}Journal of Clinical Pathology,2010,(07):599-603.
  • 8Luo JH,Ren B,Keryanov S. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas[J].{H}HEPATOLOGY,2006,(04):1012-1024.
  • 9DeBaun MR,Ess J,Saunders S. Simpson Golabi Behmel syndrome:progress toward understanding the molecular basis for overgrowth,malformation,and cancer predisposition[J].{H}Molecular Genetics and Metabolism,2001,(04):279-286.
  • 10Iglesias BV,Centeno G,Pascuccelli H. Expression pattern of Glypican-3 (GPC3) during human embryonic and fetal development[J].{H}Histology and Histopathology,2008,(11):1333-1340.

引证文献8

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部